A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...

A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, ...

Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...

SoundHealth, the medical technology company behind the SONU Band, has launched the first-ever medical-grade Android app ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...

A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox ...

A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

However, the story of her brother and the end of his life is what she holds dear to her heart. In the workshop, and later in ...